Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
14.11. | How One Optum Exec Is Handling the Influx of Digital Mental Health Solutions | ||
13.11. | High Labor Costs Continue to Plague Providers, Data Shows | ||
13.11. | Johnson & Johnson Takes the 340B Drug Rebate Fight to Federal Court | ||
13.11. | The Rapid Growth of GLP-1s and Their Impact on Bariatric Surgery | ||
13.11. | Trump, RFK Jr., and the Healthcare Bombshell No One Sees Coming | ||
13.11. | Where Can Self-Insured Employers Look to Find Healthcare Savings? | ||
13.11. | Where Medicare Advantage Goes From Here | ||
13.11. | What Might the Future of Prescription Drugs Look Like Under Trump? | ||
12.11. | Fort Health Secures $5.5M to Expand Access to Integrated Pediatric Mental Health Care | ||
12.11. | Neurogene Gene Therapy Shows Signs of Efficacy in Small Study, But an Adverse Event Spooks Investors | ||
12.11. | Unlocking the Future of Radioligand Therapy: From Discovery to Delivering at Scale | ||
12.11. | How One Massachusetts Maternal Mental Health Program Scaled Across the Country | ||
11.11. | How 4 Health Systems Are Partnering with Microsoft | ||
11.11. | AbbVie Drug Expected to Rival Bristol Myers's New Schizophrenia Med Flunks Phase 2 Test | ||
11.11. | Closing Staffing Gaps in Healthcare by Utilizing Diverse Pipelines of Contingent Talent | ||
11.11. | An Integrated Approach to Optimizing Specialty Pharmacy and Accelerating Performance | ||
11.11. | A Sneak Peek of INVEST 2025 Agenda | ||
11.11. | How Can Healthcare Organizations Earn Trust with Marginalized Communities? | ||
10.11. | Inside Providence's Health Equity & Medicaid Strategy | ||
10.11. | 'Serial Killing' Cell Therapy From Autolus Lands FDA Approval in Blood Cancer | ||
10.11. | Driving Genetic Testing Adoption and Improved Patient Care through Health Data Intelligence | ||
10.11. | The Trust-Building Playbook: 5 Tips Every Digital Health Marketer Needs to Know | ||
08.11. | Measuring Impact in Digital Youth Mental Health: What Investors Look For | ||
08.11. | FDA Takes Step Toward Removal of Ineffective Decongestants From the Market | ||
08.11. | The Startup Economy is Turbulent. Here's How Founders Can Recognize and Avoid Common Pitfalls |